Sun Pharmaceutical Industries
Launch date
Employees
Market cap
$60.8b
Enterprise valuation
$58.7b (Public information from Sep 2024)
Share price
INR1865.75 SUNPHARMA.NS
Mumbai Maharashtra (HQ)
Financials
Estimates*
INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 331.4b | 384.3b | 432.8b | 477.6b | 531.5b | 590.0b | 631.5b |
% growth | 3 % | 16 % | 13 % | 10 % | 11 % | 11 % | 7 % |
EBITDA | 90.5b | 116.0b | 122.8b | 142.9b | 146.4b | 167.0b | 181.3b |
% EBITDA margin | 27 % | 30 % | 28 % | 30 % | 28 % | 28 % | 29 % |
Profit | 29.0b | 32.7b | 84.7b | 95.8b | 113.1b | 130.7b | 145.6b |
% profit margin | 9 % | 9 % | 20 % | 20 % | 21 % | 22 % | 23 % |
EV / revenue | 4.1x | 5.4x | 5.2x | 7.8x | 7.9x | 7.0x | 6.5x |
EV / EBITDA | 15.1x | 17.9x | 18.5x | 26.1x | 28.6x | 24.7x | 22.4x |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | Acquisition | ||
Total Funding | - |
Recent News about Sun Pharmaceutical Industries
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Sun Pharmaceutical Industries
EditACQUISITION by Sun Pharmaceutical Industries Nov 2012
ACQUISITION by Sun Pharmaceutical Industries Sep 2015
ACQUISITION by Sun Pharmaceutical Industries Jan 2023
ACQUISITION by Sun Pharmaceutical Industries Apr 2014
exited
exited
ACQUISITION by Sun Pharmaceutical Industries Nov 2016